RPS launches open access journal for pharmacology research

RPS Pharmacy and Pharmacology Reports will cover pharmaceutical research from drug discovery through to drug development.
RPS Pharmacy and Pharmacology Reports

The Royal Pharmaceutical Society (RPS) has launched RPS Pharmacy and Pharmacology Reports, an open-access journal with an interdisciplinary focus.

The peer-reviewed journal will cover the lifespan of pharmaceutical research from drug discovery to drug development, including pharmacy, pharmacology, chemistry, biochemistry, physiology and microbiology.

Tony Scully, publisher of The Pharmaceutical Journal, said that RPS Pharmacy and Pharmacology Reports “aims to serve our growing community of pharmaceutical scientists and perfectly complements our portfolio of research journals at the Royal Pharmaceutical Society”.

The journal is published in partnership with Oxford University Press and is edited by Dennis Douroumis, professor of pharmaceutical technology and process engineering at the University of Greenwich.

Speaking to The Pharmaceutical Journal in August 2022, Douroumis said the journal was “focused on research that is novel and innovative”.

“There is a sister journal, Journal of Pharmacy and Pharmacology (JPP), but the idea was to have a system for open access. The JPP does it at some point, but we wanted a pure journal for open access,” he said.

In a statement issued upon the journal’s launch, he added that the editorial board “encourage submissions from researchers all over the world to share their work in this multidisciplinary open access journal”.

RPS members are eligible for a 20% discount on the article processing charge.

Last updated
The Pharmaceutical Journal, PJ, September 2022, Vol 309, No 7965;309(3965)::DOI:10.1211/PJ.2022.1.158729

    Please leave a comment 

    You may also be interested in